Filtered By:
Specialty: Dermatology
This page shows you your search results in order of relevance. This is page number 9.
Order by Relevance | Date
Total 354 results found since Jan 2013.
Newly identified phenotypes in a FIP1L1/PDGFRA‐associated paediatric HES patient: thrombocytosis, mHPA, young stroke and blindness
Source: Journal of the European Academy of Dermatology and Venereology - February 27, 2014 Category: Dermatology Authors: K. Zeng, L. Li, L. Huang, Y.‐H. Liang Tags: Letter to the Editor Source Type: research
Bullous pemphigoid and comorbidities: a case-control study in Portuguese patients
CONCLUSIONS: The results of this study substantiate the association between BP and neurological diseases. In addition, they highlight the potential complications associated with the treatment of BP.
Source: Anais Brasileiros de Dermatologia - April 25, 2014 Category: Dermatology Source Type: research
Steroid treatment can improve the impaired quality of life of patients with acquired idiopathic generalized anhidrosis
This article is protected by copyright. All rights reserved.
Source: British Journal of Dermatology - July 24, 2014 Category: Dermatology Authors: A. Fukunaga, M. Hatakeyama, M. Tsujimoto, Y. Oda, K. Washio, C. Nishigori Tags: Correspondence Source Type: research
Steroid treatment can improve the impaired quality of life of patients with acquired idiopathic generalized anhidrosis.
This article is protected by copyright. All rights reserved.
PMID: 25060903 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - July 24, 2014 Category: Dermatology Authors: Fukunaga A, Hatakeyama M, Tsujimoto M, Oda Y, Washio K, Nishigori C Tags: Br J Dermatol Source Type: research
Segmental immune disorders resulting from neurologic injuries
Abstract: The immunocompromised cutaneous district (ICD) is a novel pathogenic concept that refers to the occurrence of opportunistic skin disorders (such as infections, malignancies, and immune diseases) at a cutaneous site previously marked by a damaging event, usually involving the local lymph network or peripheral sensory nerves. In addition to herpetic infections, which are notoriously harmful for sensory nerve fibers and therefore already included among the potential causes of ICD, there are a large and variegate group of further neurologic diseases, both peripheral (carpal tunnel syndrome, facial nerve palsy, and tr...
Source: Clinics in Dermatology - August 25, 2014 Category: Dermatology Authors: Vincenzo Piccolo, Teresa Russo, Domenico Bove, Adone Baroni Source Type: research
Cardiovascular outcomes and systemic anti‐inflammatory drugs in patients with severe psoriasis: 5‐year follow‐up of a Danish nationwide cohort
ConclusionSystemic anti‐inflammatory treatment with methotrexate was associated with significantly lower rates of cardiovascular events during long‐term follow‐up compared to patients treated with other antipsoriatic therapies. The treatment strategy in patients with severe psoriasis may have an impact on cardiovascular outcomes and randomized trials to evaluate the cardiovascular safety and efficacy of systemic antipsoriatic therapies are called for.
Source: Journal of the European Academy of Dermatology and Venereology - October 10, 2014 Category: Dermatology Authors: O. Ahlehoff, L. Skov, G. Gislason, R. Gniadecki, L. Iversen, L.E. Bryld, S. Lasthein, J. Lindhardsen, S.L. Kristensen, C. Torp‐Pedersen, P.R. Hansen Tags: Original Article Source Type: research
Cutaneous sensory disorder.
Authors: Gupta MA, Gupta AK
Abstract
Cutaneous sensory disorder (CSD) represents a heterogeneous clinical situation where the patient presents with either disagreeable skin sensations (ie, itching, burning, stinging) or pain (ie, allodynia) and/or negative sensory symptoms (ie, numbness, hypoaesthesia). These patients have no apparent diagnosable dermatologic or medical condition that explains the cutaneous symptom, and typically have negative findings upon medical workup. Skin regions that normally have a greater density of epidermal innervation tend to be more susceptible to the development of CSD. CSDs can affec...
Source: Seminars in Cutaneous Medicine and Surgery - November 14, 2014 Category: Dermatology Tags: Semin Cutan Med Surg Source Type: research
A case of acquired idiopathic pterygium inversum unguis.
We present an unusual case of acquired idiopathic PIU of the 10 fingernails in a 22-year-old man.
PMID: 24966638 [PubMed]
Source: Annals of Dermatology - December 2, 2014 Category: Dermatology Tags: Ann Dermatol Source Type: research
Rate ratio of comorbidity high in SLE patients under 40
MANCHESTER, U.K. – When systemic lupus erythematosus (SLE) occurs before age 40, patients run a high relative risk of end-stage renal disease, data from a retrospective U.K.-based cohort study have shown.
While the risk for cardiovascular disease and stroke has been reported previously,...
Source: Skin and Allergy News - May 20, 2015 Category: Dermatology Tags: CME-candidate FPN Conferences IMN Conferences RHEUM Conference News SAN Conference News FPN News FPN Nephrology FPN Rheumatology HOSP News Source Type: news
Stroke, blindness are risks of unintended injection of fillers into blood vessels
Rare but serious side effects can result when soft tissue fillers are unintentionally injected into blood vessels in the face, according to a press release from the Food and Drug Administration.
Blood vessels can be blocked and blood flow restricted following unintentional soft tissue filler...
Source: Skin and Allergy News - May 28, 2015 Category: Dermatology Tags: SAN Clinical News SAN News SAN Aesthetic Dermatology Source Type: news
Tildrakizumab (MK‐3222), an Anti‐ IL‐23p19 Monoclonal Antibody, Improves Psoriasis in a Phase 2b Randomized Placebo‐ Controlled Trial
ConclusionsTildrakizumab demonstrated superior efficacy vs. placebo that was maintained up to 52 weeks of treatment and for an additional 20 weeks after cessation of study therapy. Tildrakizumab was generally safe and well tolerated. These results suggest that IL‐23p19 is a key target for suppressing psoriasis. ClinicalTrials Registry # NCT01225731This article is protected by copyright. All rights reserved.
Source: British Journal of Dermatology - June 1, 2015 Category: Dermatology Authors: K. Papp, D. Thaçi, K. Reich, E. Riedl, R.G. Langley, J.G. Krueger, A.B. Gottlieb, H. Nakagawa, E.P. Bowman, A. Mehta, Q. Li, Y. Zhou, R. Shames Tags: Original Article Source Type: research
Haptic characterization of human skin in vivo in response to shower gels using a magnetic levitation device
ConclusionThe results of this study show that different shower gels do have significant measurable differences in their effects on skin properties, and that using a high‐precision haptic device can be a useful tool for quantifying the haptic properties of skin in vivo.
Source: Skin Research and Technology - June 3, 2015 Category: Dermatology Authors: R. Yardley, A. Fan, J. Masters, S. Mascaro Tags: Original Article Source Type: research
Tildrakizumab (MK-3222), an Anti- IL-23p19 Monoclonal Antibody, Improves Psoriasis in a Phase 2b Randomized Placebo- Controlled Trial.
CONCLUSIONS: Tildrakizumab demonstrated superior efficacy vs. placebo that was maintained up to 52 weeks of treatment and for an additional 20 weeks after cessation of study therapy. Tildrakizumab was generally safe and well tolerated. These results suggest that IL-23p19 is a key target for suppressing psoriasis. ClinicalTrials Registry # NCT01225731 This article is protected by copyright. All rights reserved.
PMID: 26042589 [PubMed - as supplied by publisher]
Source: The British Journal of Dermatology - June 3, 2015 Category: Dermatology Authors: Papp K, Thaçi D, Reich K, Riedl E, Langley RG, Krueger JG, Gottlieb AB, Nakagawa H, Bowman EP, Mehta A, Li Q, Zhou Y, Shames R Tags: Br J Dermatol Source Type: research
Transient memory impairment and transient global amnesia induced by photodynamic therapy
This article is protected by copyright. All rights reserved.
Source: British Journal of Dermatology - June 30, 2015 Category: Dermatology Authors: M. Reinholz, M.V. Heppt, F. Hoffmann, N. Lummel, T. Ruzicka, P. Lehmann, C. Berking Tags: Case Report Source Type: research
PodMed: A Medical News Roundup From Johns Hopkins (with audio)
(MedPage Today) -- This week's topics include citrus and melanoma, a new oral medication for obesity, stroke treatment guidelines, and a vaccine for Helicobacter pylori.
Source: MedPage Today Dermatology - July 5, 2015 Category: Dermatology Source Type: news
